Hati-Cancer
Lisbon
About Hati-Cancer
Hati-Cancer is developing new drugs for metastatic cancer targeted therapy. The company was composed of 4 founders: Bruno Azevedo (CEO), Miguel Sousa (CTO), Ricardo Soares (COO), Rodrigo Pires (CCO), who are all Electrical Engineers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $121.6K
- Last round: Series Unknown (Feb 2021)
- Website: haticancer.weebly.com
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/hati-cancer-36416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.